PURPOSE: To determine whether a dose-response relationship exists between caffeine and 2000-m rowing performance. METHODS: In this randomized, placebo-controlled, double-blind crossover study, 10 competitive male rowers (mean +/- SD: age = 20.6 +/- 1.4 yr, body mass = 87.7 +/- 10.5 kg, height = 186.8 +/- 6.8 cm, (.)VO2peak = 5.1 +/- 0.6 L x min(-1)) consumed 2, 4, or 6 mg x kg(-1) caffeine or a placebo 60 min before completing a 2000-m time trial on a rowing ergometer. The trials were preceded by a 24-h standardized diet (including a light preexercise meal of 2 g x kg(-1) CHO), and subjects were tested preexercise for hydration, caffeine abstinence, and blood glucose concentrations. RESULTS:Time trial performance was not significantly different across the three caffeine doses or placebo (P = 0.249). After the three caffeine trials, postexercise plasma glucose and lactate concentrations were higher compared with the placebo trial (P < 0.05). Plasma caffeine concentrations after 60 min of ingestion were lower than the values reported previously by others following the same dose, and there was considerable interindividual variation in plasma caffeine concentrations in response to the various caffeine doses. CONCLUSIONS: The large interindividual response to the caffeine doses suggests that individual characteristics need to be considered when administering caffeine for performance enhancement. In addition, preexercise feeding may significantly affect plasma caffeine concentrations and the potential for caffeine to improve performance.
RCT Entities:
PURPOSE: To determine whether a dose-response relationship exists between caffeine and 2000-m rowing performance. METHODS: In this randomized, placebo-controlled, double-blind crossover study, 10 competitive male rowers (mean +/- SD: age = 20.6 +/- 1.4 yr, body mass = 87.7 +/- 10.5 kg, height = 186.8 +/- 6.8 cm, (.)VO2peak = 5.1 +/- 0.6 L x min(-1)) consumed 2, 4, or 6 mg x kg(-1) caffeine or a placebo 60 min before completing a 2000-m time trial on a rowing ergometer. The trials were preceded by a 24-h standardized diet (including a light preexercise meal of 2 g x kg(-1) CHO), and subjects were tested preexercise for hydration, caffeine abstinence, and blood glucose concentrations. RESULTS: Time trial performance was not significantly different across the three caffeine doses or placebo (P = 0.249). After the three caffeine trials, postexercise plasma glucose and lactate concentrations were higher compared with the placebo trial (P < 0.05). Plasma caffeine concentrations after 60 min of ingestion were lower than the values reported previously by others following the same dose, and there was considerable interindividual variation in plasma caffeine concentrations in response to the various caffeine doses. CONCLUSIONS: The large interindividual response to the caffeine doses suggests that individual characteristics need to be considered when administering caffeine for performance enhancement. In addition, preexercise feeding may significantly affect plasma caffeine concentrations and the potential for caffeine to improve performance.
Authors: Juan Del Coso; Víctor E Muñoz-Fernández; Gloria Muñoz; Valentín E Fernández-Elías; Juan F Ortega; Nassim Hamouti; José C Barbero; Jesús Muñoz-Guerra Journal: PLoS One Date: 2012-02-14 Impact factor: 3.240
Authors: Mark Glaister; Benjamin Henley Williams; Daniel Muniz-Pumares; Carlos Balsalobre-Fernández; Paul Foley Journal: PLoS One Date: 2016-08-17 Impact factor: 3.240
Authors: Carlos Puente; Javier Abián-Vicén; Juan José Salinero; Beatriz Lara; Francisco Areces; Juan Del Coso Journal: Nutrients Date: 2017-09-19 Impact factor: 5.717